Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06340646

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

Led by Washington University School of Medicine · Updated on 2025-07-11

990

Participants Needed

1

Research Sites

223 weeks

Total Duration

On this page

Sponsors

W

Washington University School of Medicine

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches that direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research, and to investigate the impact of directly engaging participants in decisions regarding returning of genomic results on participants' health and satisfaction. Participants in this study will be presented with the choice of types of genomic results to receive, and the Engagement Optimization Unit (EOU) will investigate the impact of this intervention on participant knowledge, expectations of benefit, personal utility, and decisional conflict.

CONDITIONS

Official Title

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with cholangiocarcinoma, multiple myeloma, or early onset colon or rectal cancer
  • If diagnosed with multiple myeloma, must be African-American
  • If diagnosed with colon or rectal cancer, must be African-American and no older than 65 years at diagnosis
  • At least 18 years old
  • Able to understand and willing to sign an IRB-approved written informed consent document
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110

Actively Recruiting

Loading map...

Research Team

G

Graham Colditz, M.D., DrPH, MPH

CONTACT

B

Bettina Drake, Ph.D., MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here